It will only help. More liquidity makes it easier for MSB retail to take profits to reinvest in the next 10+ bagger, and CYP fits that bill with the deep clinical pipeline nearing an inflection point when GvHD and Knee OA trials results read out over the next 9-12 months.
CYP Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)